233 related articles for article (PubMed ID: 32741487)
1. Management of Hypothalamic Obesity.
Müller HL
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):533-552. PubMed ID: 32741487
[TBL] [Abstract][Full Text] [Related]
2. Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review.
Ni W; Shi X
World Neurosurg; 2018 Oct; 118():e59-e71. PubMed ID: 29945001
[TBL] [Abstract][Full Text] [Related]
3. Approach to the Patient With Hypothalamic Obesity.
Shoemaker AH; Tamaroff J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1236-1242. PubMed ID: 36413492
[TBL] [Abstract][Full Text] [Related]
4. Childhood craniopharyngioma - current status and recent perspectives in diagnostics and treatment.
Müller HL
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):1-2. PubMed ID: 25503668
[No Abstract] [Full Text] [Related]
5. Liraglutide 3mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma.
Bretault M; Carette C; Zaharia R; Vychnevskaia K; Bouillot JL; Czernichow S; Raffin-Sanson ML
Diabetes Metab; 2020 Nov; 46(6):514-515. PubMed ID: 31362076
[No Abstract] [Full Text] [Related]
6. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.
van Iersel L; Brokke KE; Adan RAH; Bulthuis LCM; van den Akker ELT; van Santen HM
Endocr Rev; 2019 Feb; 40(1):193-235. PubMed ID: 30247642
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma.
Erfurth EM
Neuroendocrinology; 2020; 110(9-10):767-779. PubMed ID: 32580186
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic obesity.
Babcock Gilbert S; Roth LW
Minerva Endocrinol; 2015 Mar; 40(1):61-70. PubMed ID: 25370939
[TBL] [Abstract][Full Text] [Related]
9. Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma.
Rottembourg D; O'Gorman CS; Urbach S; Garneau PY; Langer JC; Van Vliet G; Hamilton J; Huot C
J Pediatr Endocrinol Metab; 2009 Sep; 22(9):867-72. PubMed ID: 19960898
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases.
Wu W; Sun Q; Zhu X; Xiang B; Zhang Q; Miao Q; Wang Y; Li Y; Ye H
Front Endocrinol (Lausanne); 2021; 12():694213. PubMed ID: 34394000
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients.
Müller HL
Minerva Endocrinol; 2017 Dec; 42(4):356-375. PubMed ID: 28181780
[TBL] [Abstract][Full Text] [Related]
12. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.
van Santen HM; Schouten-Meeteren AY; Serlie M; Meijneke RW; van Trotsenburg AS; Verberne H; Holleman F; Fliers E
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):53-7. PubMed ID: 25514327
[TBL] [Abstract][Full Text] [Related]
13. Creative and Innovative Methods and Techniques for the Challenges in the Management of Adult Craniopharyngioma.
Takami H; Velásquez C; Asha MJ; Oswari S; Almeida JP; Gentili F
World Neurosurg; 2020 Oct; 142():601-610. PubMed ID: 32987616
[TBL] [Abstract][Full Text] [Related]
14. Craniopharyngioma and hypothalamic obesity in children.
Vinchon M; Weill J; Delestret I; Dhellemmes P
Childs Nerv Syst; 2009 Mar; 25(3):347-52. PubMed ID: 19057910
[TBL] [Abstract][Full Text] [Related]
15. A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients.
Roth CL; Blevins JE; Ralston M; Elfers C; Ogimoto K; Kaiyala KJ; Morton GJ
Pediatr Res; 2011 Mar; 69(3):230-6. PubMed ID: 21372758
[TBL] [Abstract][Full Text] [Related]
16. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up.
Muller HL
Horm Res; 2008; 69(4):193-202. PubMed ID: 18204266
[TBL] [Abstract][Full Text] [Related]
17. The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort.
van Iersel L; Meijneke RWH; Schouten-van Meeteren AYN; Reneman L; de Win MM; van Trotsenburg ASP; Bisschop PH; Finken MJJ; Vandertop WP; van Furth WR; van Santen HM
Pediatr Blood Cancer; 2018 May; 65(5):e26911. PubMed ID: 29314661
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon.
Roth CL; Zenno A
Front Endocrinol (Lausanne); 2023; 14():1256514. PubMed ID: 37780616
[TBL] [Abstract][Full Text] [Related]
19. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy.
Inge TH; Pfluger P; Zeller M; Rose SR; Burget L; Sundararajan S; Daniels SR; Tschöp MH
Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):606-9. PubMed ID: 17643131
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance.
Maniatis AK; Simmons JH; Zeitler PS
Curr Opin Pediatr; 2005 Apr; 17(2):275-9. PubMed ID: 15800425
[No Abstract] [Full Text] [Related]
[Next] [New Search]
